Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jun 6:2018:18-0034.
doi: 10.1530/EDM-18-0034. eCollection 2018.

Adrenal crisis in a 14-year-old boy 12 years after hematopoietic stem cell transplantation

Affiliations

Adrenal crisis in a 14-year-old boy 12 years after hematopoietic stem cell transplantation

Theresa Penger et al. Endocrinol Diabetes Metab Case Rep. .

Abstract

We report on a boy of Albanian descent with the history of juvenile myelomonocytic leukemia (JMML). JMML was diagnosed at the age of 17 months and treated by hematopoietic stem cell transplantation (HSCT). At the age of 14.3 years, about 12 years after HSCT, he was hospitalized with an adrenal crisis. Hormone findings were consistent with primary adrenal insufficiency. Autoimmune adrenalitis was confirmed by positive autoantibodies against 21-hydroxylase and adrenal tissue. Since autoimmune Hashimoto thyroiditis was already known from the age of 9 years, we assume that both diseases are part of the spectrum of autoimmune polyglandular syndrome (APS) type 2. APS type 2 is a rare endocrine disease characterized by Addison's disease along with autoimmune thyroid disease and/or type 1 diabetes.

Learning points: Endocrine sequelae after hematopoietic stem cell transplantation (HSCT) are common and can develop over a long period.Primary adrenal insufficiency after HSCT is absolutely rare.The combination of adrenal autoimmune disease and Hashimoto thyroiditis is consistent with autoimmune polyglandular syndrome type 2.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Schechter T, Pole JD, Darmawikarta D, Doyle J, Ali M, Egeler M, Gassas A, Irwin MS, Greenberg M, Nathan PC. Late mortality after hematopoietic SCT for a childhood malignancy. Bone Marrow Transplantation 2013. 48 1291–1295. (10.1038/bmt.2013.64) - DOI - PubMed
    1. Bresters D, van Gils IC, Kollen WJ, Ball LM, Oostdijk W, van der Bom JG, Egeler RM. High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study. Bone Marrow Transplantation 2010. 45 79–85. (10.1038/bmt.2009.92) - DOI - PubMed
    1. Wilhelmsson M, Vatanen A, Borgström B, Gustafsson B, Taskinen M, Saarinen-Pihkala UM, Winiarski J, Jahnukainen K. Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up. Bone Marrow Transplantation 2015. 50 850–857. (10.1038/bmt.2015.43) - DOI - PubMed
    1. Legault L, Bonny Y. Endocrine complications of bone marrow transplantation in children. Pediatric Transplantation 1999. 3 60–66. (10.1034/j.1399-3046.1999.00009.x) - DOI - PubMed
    1. Jung MH, Cho KS, Lee JW, Chung NG, Cho B, Suh BK, Kim HK, Lee BC. Endocrine complications after hematopoietic stem cell transplantation during childhood and adolescence. Journal of Korean Medical Science 2009. 24 1071–1077. (10.3346/jkms.2009.24.6.1071) - DOI - PMC - PubMed

LinkOut - more resources